National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 1411961

History of Changes from the VAERS Wayback Machine

First Appeared on 7/23/2021

VAERS ID: 1411961
VAERS Form:2
Vaccin­ation / Manu­facturer Lot / Dose Site / Route

Administered by: Other      Purchased by: ??
Symptoms: Urticaria

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? Yes
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Hypercholesterolaemia; Hypertension
Diagnostic Lab Data:
CDC 'Split Type': JPPFIZER INC2021656916

Write-up: Urticaria; This is a spontaneous report from a contactable physician received via COVID-19 Adverse Event Self-Reporting Solution (COVAES). The patient was a non-pregnant 70-year-old female. It was unknown whether the patient receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received Hypertension, Hypercholesterolaemia prescription drugs within 2 weeks of vaccination. It was unknown whether the patient had been diagnosed with COVID-19. On 31May2021(the day of vaccination), the patient received the first single dose of BNT162B2 (COMIRNATY, Solution for injection, Lot number unknown) intramuscular for COVID-19 immunization. On 03Jun2021(the day after vaccination), the patient experienced Urticaria. The reporter stated the event(s) results in doctor or other healthcare professional office/clinic visit. The outcome of the event was not recovered with treatment including Bepotastine Besilate orally. It was unknown whether the patient has been tested for COVID-19 since the vaccination. Information about lot/batch number cannot be obtained.

New Search

Link To This Search Result:

Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166